SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
UPB

Upstream Bio, Inc. (UPB)

NASDAQ: UPB · Real-Time Price · USD
Healthcare · Biotechnology
$2.15-$0.63 (-22.66%)
 
Market cap
$118M
Insider Score
Analyst consensus
Insider Score
34/ 100
UPB Insider Score
Bearish

0 qualifying trades · 0 insiders · $0 bought in the last 90 days

UPB Income Statement

Fiscal PeriodQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Period EndingSep 30, 2026Jun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025
Revenue$395.00 K$773.00 K$1.03 M$668.00 K$683.00 K
Revenue Growth (YoY)-42.17 %————
Cost of Revenue—————
Gross Profit—————
SG&A Expense$7.17 M$7.05 M$8.08 M$6.67 M$5.54 M
R&D Expense$36.61 M$36.09 M$36.56 M$40.17 M$32.98 M
Operating Expenses$43.77 M$43.14 M$44.65 M$46.84 M$38.52 M
Operating Income-$43.38 M-$42.37 M-$43.62 M-$46.17 M-$37.83 M
Pretax Income-$41.19 M-$39.70 M-$40.59 M-$42.46 M-$33.75 M
Tax Provision—————
Net Income-$41.19 M-$39.70 M-$40.59 M-$42.46 M-$33.75 M
EPS (Basic)-$0.75-$0.73-$0.75-$0.78-$0.63
EPS (Diluted)-$0.75-$0.73-$0.75-$0.78-$0.63
Shares Outstanding54.78 M54.57 M54.33 M54.24 M53.93 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Upstream Bio, Inc. (UPB) Financials: Revenue, Earnings & Balance Sheet | InsiderBuying.com